
MedExecWomen 2025
Creating Competitive Advantage in a Dynamic Healthcare Environment
April 10, 2025 | Westin Boston Seaport
MedExecWomen is proud to host this exclusive annual conference that brings together high-level female leaders in medtech to explore industry trends, enhance executive leadership capabilities, and cultivate powerful professional relationships.
Speakers
-
Andrea Jackson
Partner
Northpond Ventures -
Abigail Epane-Osuala
Chief DEI Officer & HR Strategic Initiatives
GE Healthcare -
Nancy Briefs
Co-Founder, President & CEO
Altrix Bio -
Sonal Patel
Vice President, Business Development Strategy & Ventures
Zimmer Biomet -
Simran Sabharwal
Vice President, US Commercial Marketing, Orthopedics
Smith + Nephew -
Anne Smart
Principal, Head of Strategy & Portfolio Development, Medtech
ZS -
Cecilia Soriano
President, Infusion Therapies and Technologies
Baxter -
April Lopez
SVP Finance
Philips -
Geraldine McGinty
Academic Medicine Leader, Board Member, Strategist
Weill Cornell Medicine -
Gwen Watanabe
Managing Director
HIG Capital -
Heather Knight
Chief Operating Officer
Baxter -
Jessica Hameline
Corporate Vice President, Strategy & Business Development
Hologic -
Kathryn Unger
Vice President, Environmental, Social and Governance (ESG)
Boston Scientific -
Beth McCombs
EVP & CTO
BD -
Kali Benios
Head of Strategy
Medtronic Surgical -
Lisa Blair Davis
WW VP of HR, Medtech
J&J -
Liz Hardin
Managing Director & Partner
BCG -
Luna Corbetta
Partner, Organization & Workforce Transformation
PwC -
Kirk Taylor, MD
President & CEO
MLSC -
Maria Ghazal
President & CEO
Healthcare Leadership Council -
Mary Miller Sallah
Chief Operating Officer
Carna Health -
Maureen Mazurek
Chief Sustainability & EHS Offcer
BD -
Michelle Fox
Corporate VP & Chief Medical Officer
Teleflex -
Leslie Storms
President, US DePuy Synthes
Johnson & Johnson Medtech -
Tracy Warren
Senior Managing Director
American Heart Association Ventures -
Stacey Pugh
CEO
Endogenex -
Tracy MacNeal
President and CEO
Materna Medical -
Jennie Xue
Senior Managing Director
Guggenheim Partners -
Laura Mantoura
Managing Director
Russell Reynolds Associates -
Mira Sahney
Board Member
Claria Medical -
Stacy Braun
Consultant
Russell Reynolds Associates
Agenda
The agenda is being continuously updated, please check back for speaker updates.
The Westin Boston Seaport District
425 Summer Street, Boston, MA 02210
7:30–8:15 Breakfast
8:15–8:30 Welcome: Introduction to MedExecWomen
8:30–9:00 Opening Keynote
Gaining the Edge: Competitive Strategies in the Evolving MedTech Landscape
Geraldine McGinty, Academic Medicine Leader, Board Member, Strategist, Weill Cornell Medicine
What are the critical challenges and emerging opportunities facing medtech over the next five years? How do we gain competitive advantage in such a dynamic industry? Drawing on extensive global experience across clinical practice, corporate leadership, and change management, Dr. McGinty will share strategic insights to drive meaningful advancements in global healthcare delivery.
Geraldine McGinty is an internationally recognized expert in health care strategy and imaging economics, a Radiologist, and an unwavering advocate for patient-centered quality care. At Weill Cornell Medicine she is a Professor of Clinical Radiology, Senior Associate Dean for Clinical Affairs and teaches in the Healthcare Leadership program in the business school. She was the first female president of the American College of Radiology and is an advocate for the intersection of digital transformation and healthcare. Dr McGinty is a respected independent director with experience on public and private MedTech companies boards and for the national foreign direct investment agency for Ireland.
9:00–9:45 Panel 1
Leading Through Economic Fluctuations and Global Uncertainties
Moderated by: Anne Smart, Principal, Head of Strategy & Portfolio Development, Medtech, ZS
Kali Benios, Head of Strategy, Medtronic Surgical
Jessica Hameline, Corporate Vice President, Strategy & Business Development, Hologic
Tracy MacNeal, President and CEO, Materna
Gwen Watanabe, Managing Director, HIG Capital
Medtech leaders are evolving their corporate strategies and business model to adapt to sustained macroeconomic uncertainty and evolving industry trends - supply chain disruption, trade tensions, policy and regulation changes, inflation and increasing healthcare spend pressure. We will gain insights from MedTech companies who are reinventing themselves and navigating these uncertainties to catch the next wave of value creation.
9:45–10:15 Networking Break
10:15–11:00 Panel 2
Change Management and Adaptive Leadership in MedTech: Strategies for Organizational Success
Moderated by: Luna Corbetta, Partner, Organization & Workforce Transformation, PwC
Lisa Blair Davis, WW Vice President of Human Resources, Med Tech, J&J
Abigail Epane-Osuala, Chief DEI Officer & HR Strategic Initiatives, President GEHC Foundation, GE Healthcare
Stacey Pugh, CEO, Endogenex
Cecilia Soriano, President, Infusion Therapies and Technologies, Baxter
The ability to manage change and lead effectively is invaluable in an industry characterized by rapid innovation, market pressures and regulatory evolution. This panel will explore innovative approaches to change management and adaptive leadership in medtech, with a particular focus on:
Cultural Transformation: Strategies for fostering a culture of innovation and resilience.
Emotional Intelligence: Harnessing EQ to navigate the human aspects of technological and organizational shifts.
Keeping Pace: Cultivating a culture of agility and continuous improvement
Inclusive Leadership: The role of leadership in navigating complex stakeholder ecosystems
11:00–12:00 Breakout Session 1
Topic A: Securing Management Commitment & Investor Capital for Your Business
Whether working in corporate medtech or the start up world, your business competes for funding. Learn best practices from leaders in the business. This breakout will tackle the strategies and challenges of making the competitive advantage of your business pitch as powerful as possible.
Moderated by: Karen Zaderej, President, CEO and Chairman of the Board (Retired), AxoGen, Inc.
Andrea Jackson, Partner, Northpond Ventures
April Lopez, SVP Finance, Philips
Simran Sabharwal, Vice President, US Commercial Marketing, Orthopedics, Smith + Nephew
Topic B: Board Leadership: Why Me and Which Board?
Women executives are recognized to bring value to company boards, whether large or small, public or private. However finding the first and the right board roles can still be a challenge. This session will share practical resources and experiences specific to MedTech executives and work through the questions of “Why me? Which board?”
Moderated by:
Stacy Braun, Consultant, Russell Reynolds Associates
Laura Mantoura, Managing Director, Russell Reynolds Associates
Panelists:
Mira Sahney, Board Member, Inogen and Claria Medical
Nancy Briefs, Co-Founder, President & CEO, Altrix Bio
Tracy Warren, Sr Managing Director, American Heart Association
12:00–1:00 Lunch
1:00–1:30 _Executive Interview
Interview with Elizabeth McCombs, EVP and Chief Technology Officer, BD
Interviewed by: Leslie Storms, President, US Orthopaedics, Johnson & Johnson MedTech
Beth McCombs serves as BD’s executive vice president and chief technology officer. In this role, she is responsible for leading all R&D activities for BD, advancing new product innovation and development from early-stage concepts through launch and sustaining the current product portfolio. She is also a member of the BD Executive Leadership Team. Prior to joining BD, McCombs spent more than 20 years at Johnson & Johnson (J&J), most recently as Vice President, R&D for Ethicon, J&J’s surgical device franchise.
McCombs serves on the New York City Economic Development Corporation (NYCEDC) Life Sciences Advisory Council, helping to guide the city’s continued growth of life sciences as supported by LifeSci NYC, a $1 billion, 10-year initiative. She has been a featured thought leader in several industry publications and conferences, and has been named in reports such as The Healthcare Technology Report’s Top 25 Women Leaders in Medical Devices of 2023 and Women We Admire’s list of Top 100 Women Leaders in Healthcare 2021.
1:30–2:30 Breakout Session 2
Topic A: Securing Management Commitment & Investor Capital for Your Business
Topic B: Board Leadership: Why Me and Which Board?
2:30–3:15 Panel 3
Balancing Growth, Innovation, and Sustainability in Health Technology
Moderated by: Liz Hardin, Managing Director & Partner, BCG
Michelle Fox, Corporate VP & Chief Medical Officer, Teleflex
Maureen Mazurek, Chief Sustainability & EHS Officer, BD
Mary Miller Sallah, Chief Operating Officer, Carna Health
Kathryn Unger, Vice President, Environmental, Social and Governance (ESG), Boston Scientific
As the global healthcare sector confronts its significant environmental impact, the medtech industry is uniquely positioned to lead by embedding sustainability as a core driver of growth and innovation. This panel will explore forward-thinking strategies that integrate biodesign principles into innovation and operations while fostering business expansion and breakthrough innovation. Attendees will gain actionable insights on how sustainability can fuel strategic objectives without compromising product quality or patient outcomes.
3:15–3:45 Networking Break
3:45–4:15 Fireside Chat
Navigating Political Headwinds: Healthcare Policy's Impact on MedTech Innovation and Growth
Maria Ghazal, President & CEO, Healthcare Leadership Council
Hosted by: Heather Knight, Chief Operating Officer, Baxter
There is a critical relationship between local and national political environments and the resulting policies that will impact the MedTech industry's ability to innovate, grow, and deliver life-saving technologies. In this session, we will address the impact of changes to political leadership at the federal and state levels.
4:15–5:00 Pitch Showcase
4:15 Pitch #1 - Akeyna (Karen Cronholm, CEO & Co-Founder)
4:25 Pitch #2 - Nanopath (Amogha Tadimety, Co-Founder & Co-CEO)
4:35 Pitch #3 - Lightfinder (Diana Mojahed, CEO & Founder)
4:45 Pitch #4 - Bloomer Tech
Moderated by: Kirk Taylor, MD, President & CEO, Mass Life Sciences Center
JUDGES
Sonal Patel, Vice President, Business Development Strategy & Ventures, Zimmer Biomet
Jennie Xue, Senior Managing Director, Guggenheim Partners
Cynthia Yee, Partner, Vensana